Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

Figure 2

Difference of survival comparing hyperfractionated or accelerated radiotherapy with hyperfractionated or accelerated radiotherapy plus simultaneous chemotherapy using cisplatin, carboplatin, mitomycin C, and 5-FU as single drug or combinations of 5-FU with one of the other drugs (Group 1b). OS = Overall survival; * = 95% confidence limits of 2 year overall survival; delta months = differences of median overall survival; LCL = lower confidence limit of median survival; UCL = upper confidence limit of median survival; N = number of patients.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us